Answers are grounded in this paper and cite their sources.
Demonstrates effective antivenom production in Escherichia coli, suggesting a new approach for broad neutralization.
H production for multivalent therapeutics requiring broad neutralization, including recombinant antivenoms.
No takes yet. Share an insight, caveat, or question.
Stargardt et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: